SCHEMBL30689362

SCHEMBL30689362

CCOP(=O)(OCC)C(Cc1nc(-c2ccc(Oc3ccccn3)cc2)no1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ PPARD Q03181 8/20 0.38
▸ PPARA Q07869 8/20 0.38
▸ ACACB O00763 7/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ IP6K1 Q92551 1/20 0.37
▸ IP6K3 Q96PC2 1/20 0.37
▸ IP6K2 Q9UHH9 1/20 0.37
▸ PSMB5 P28074 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689418 0.87 LTA4H (0.41) MITFTP53NCOA3LTA4HTSHR
SCHEMBL30689338 0.86 ACACB (0.36) MITFTP53NCOA3PPARDPPARA
SCHEMBL23588289 0.85 PPARD (0.46) MITFTP53NCOA3PPARDPPARA
SCHEMBL23588079 0.85 ACACB (0.46) MITFTP53NCOA3ACACBPSMB5
SCHEMBL30689341 0.83 ACACB (0.38) MITFTP53NCOA3LTA4HPPARD
SCHEMBL23588294 0.82 TP53 (0.39) MITFTP53NCOA3TSHRALDH1A1
SCHEMBL23588293 0.82 HTT (0.40) MITFTP53NCOA3TSHRALDH1A1
SCHEMBL25807564 0.82 TP53 (0.39) MITFTP53NCOA3TSHRALDH1A1
SCHEMBL25804401 0.82 TSHR (0.47) TP53TSHRALDH1A1MAPTMAPK1
SCHEMBL30689308 0.81 MITF (0.36) MITFTP53NCOA3PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback